BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
UTI Asset Management Company Ltd. again saw a good quarter with revenue and operating income beat.
Positive revenue deviation was due to higher yields as per new Pension Fund Regulatory and Development Authority rules while other opex included the government’s share of the same.
Opex was higher due to one-time expenses.
Systematic investment plan flows’ market share is improving since the last give quarters.
We see a strong compound annual growth rate in operating income of ~60% over FY21-23E led by a clear visibility of revenue growth, though there may be minor quarterly aberrations in opex.
Given the evident positive delta in core return on equity from 7.8% to 17.5% over FY21-23, valuation discount for UTI AMC should narrow compared to listed peers.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.